company background image
GUBRA logo

Gubra CPSE:GUBRA Stock Report

Last Price

kr.485.00

Market Cap

kr.7.9b

7D

47.0%

1Y

438.3%

Updated

21 Jun, 2024

Data

Company Financials

GUBRA Stock Overview

Operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs in Denmark and internationally.

GUBRA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Gubra A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Gubra
Historical stock prices
Current Share Pricekr.485.00
52 Week Highkr.508.00
52 Week Lowkr.83.45
Beta0
11 Month Change56.45%
3 Month Change61.67%
1 Year Change438.29%
33 Year Changen/a
5 Year Changen/a
Change since IPO340.91%

Recent News & Updates

Gubra A/S' (CPH:GUBRA) Shares Climb 25% But Its Business Is Yet to Catch Up

Jun 19
Gubra A/S' (CPH:GUBRA) Shares Climb 25% But Its Business Is Yet to Catch Up

Subdued Growth No Barrier To Gubra A/S (CPH:GUBRA) With Shares Advancing 60%

Mar 07
Subdued Growth No Barrier To Gubra A/S (CPH:GUBRA) With Shares Advancing 60%

Recent updates

Gubra A/S' (CPH:GUBRA) Shares Climb 25% But Its Business Is Yet to Catch Up

Jun 19
Gubra A/S' (CPH:GUBRA) Shares Climb 25% But Its Business Is Yet to Catch Up

Subdued Growth No Barrier To Gubra A/S (CPH:GUBRA) With Shares Advancing 60%

Mar 07
Subdued Growth No Barrier To Gubra A/S (CPH:GUBRA) With Shares Advancing 60%

Shareholder Returns

GUBRADK Life SciencesDK Market
7D47.0%-3.9%0.06%
1Y438.3%-15.6%39.6%

Return vs Industry: GUBRA exceeded the Danish Life Sciences industry which returned -16.2% over the past year.

Return vs Market: GUBRA exceeded the Danish Market which returned 40.4% over the past year.

Price Volatility

Is GUBRA's price volatile compared to industry and market?
GUBRA volatility
GUBRA Average Weekly Movement10.9%
Life Sciences Industry Average Movement5.9%
Market Average Movement4.4%
10% most volatile stocks in DK Market9.7%
10% least volatile stocks in DK Market2.8%

Stable Share Price: GUBRA's share price has been volatile over the past 3 months.

Volatility Over Time: GUBRA's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Danish stocks.

About the Company

FoundedEmployeesCEOWebsite
2008220Henrik Blouwww.gubra.dk

Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs in Denmark and internationally. The company operates through CRO, Discovery & Partnerships, and Gubra Green segments. It offers pre-clinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, assays and molecular pharmacology, bioinformatics, bioanalysis, next gen sequencing, and 2D and 3D imaging.

Gubra A/S Fundamentals Summary

How do Gubra's earnings and revenue compare to its market cap?
GUBRA fundamental statistics
Market capkr.7.90b
Earnings (TTM)-kr.44.52m
Revenue (TTM)kr.205.01m

38.5x

P/S Ratio

-177.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GUBRA income statement (TTM)
Revenuekr.205.01m
Cost of Revenuekr.90.07m
Gross Profitkr.114.94m
Other Expenseskr.159.46m
Earnings-kr.44.52m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Aug 23, 2024

Earnings per share (EPS)-2.73
Gross Margin56.07%
Net Profit Margin-21.72%
Debt/Equity Ratio0%

How did GUBRA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.